Selenium and the thyroid

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 20, Issue 5, 2013, Pages 441-448

  Köhrle, Josef ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

autoimmune disease; goiter; selenoprotein; thyroid cancer; thyroiditis; trace element

Indexed keywords

AUTOANTIBODY; FATTY ACID; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; HORMONE PRECURSOR; LEVOTHYROXINE; LIOTHYRONINE; SELENOCYSTEINE; SELENOPROTEIN; SELENOPROTEIN P; THIOREDOXIN REDUCTASE; THYROID HORMONE; THYROXINE DEIODINASE;

ANTIBODY TITER; DEIODINATION; DRUG EFFICACY; HUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SCORING SYSTEM; THYROID FUNCTION; THYROID GLAND; WELLBEING;

ADULT; ANIMALS; CONGENITAL HYPOTHYROIDISM; HUMANS; IODIDE PEROXIDASE; MYXEDEMA; OXIDATIVE STRESS; SELENIUM; SELENOPROTEINS; THYROID GLAND;

EID: 84883656109     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/01.med.0000433066.24541.88     Document Type: Review

References (73)

1. Zimmermann MB, Andersson M. Update on iodine status worldwide. Curr Opin Endocrinol Diabetes Obes 2012; 19:382-387.
2. Li M, Eastman CJ. The changing epidemiology of iodine deficiency. Nat Rev Endocrinol 2012; 8:434-440.
3. Meisinger C, Ittermann T, Wallaschofski H, et al. Geographic variations in the frequency of thyroid disorders and thyroid peroxidase antibodies in persons without former thyroid disease within Germany. Eur J Endocrinol 2012; 167:363-371.
4. Saranac L, Zivanovic S, Bjelakovic B, et al. Why is the thyroid so prone to autoimmune disease? Horm Res Paediatr 2011; 75:157-165.
5. Laurberg P, Andersen S, Pedersen IB, et al. Prevention of autoimmune hypothyroidism by modifying iodine intake and the use of tobacco and alcohol is manoeuvring between Scylla and Charybdis. Hormones (Athens) 2013; 12:30-38.
6. Aghini Lombardi F, Fiore E, Tonacchera M, et al. The effect of voluntary iodine prophylaxis in a small rural community: the Pescopagano survey 15 years later. J Clin Endocrinol Metab 2013; 98:1031-1039.
7. Langer P, Tajtakova M, Kocan A, et al. Thyroid volume, iodine intake, autoimmune thyroid disorders, inborn factors, and endocrine disruptors: twenty-year studies of multiple effects puzzle in Slovakia. Endocr Regul 2012; 46:191-203.
8. Köhrle J, Jakob F, Contempré B, Dumont JE. Selenium, the thyroid, and the endocrine system. Endocr Rev 2005; 26:944-984. (Pubitemid 41770159)
9. Contempre B, Le Moine O, Dumont JE, et al. Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor beta (TGF-beta). Mol Cell Endocrinol 1996; 124:7-15. (Pubitemid 27042059)
10. Contempre B, Dumont JE, Denef JF, Many MC. Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. Eur J Endocrinol 1995; 133:99-109.
11. Zimmermann MB. The influence of iron status on iodine utilization and thyroid function. Annu Rev Nutr 2006; 26:367-389.
12. Zimmermann MB, Köhrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 2002; 12:867-878. (Pubitemid 35332991)
13. Mitchell AL, Hickey B, Hickey JL, Pearce SH. Trends in thyroid hormone prescribing and consumption in the UK. BMC Public Health 2009; 9:132.
14. Glaeske G, Schicktanz C. Arzneimittelreport 2012. 2012; short version: http://www.zes.uni-bremen.de/uploads/News/2012/120829-Kurzfassung-AM-Report.pdf.
15. Trocchi P, Kluttig A, Dralle H, et al. Thyroid cancer surgery in Germany: an analysis of the nationwide DRG statistics 2005-2006. Langenbecks Arch Surg 2012; 397:421-428.
16. Zimmermann MB. The effects of iodine deficiency in pregnancy and infancy. Paediatr Perinat Epidemiol 2012; 26 (Suppl 1):108-117.
17. Contempré B, Duale NL, Dumont JE, et al. Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clin Endocrinol (Oxf) 1992; 36:579-583.
18. Xu J, Liu XL, Yang XF, et al. Supplemental selenium alleviates the toxic effects of excessive iodine on thyroid. Biol Trace Elem Res 2011; 141:110-118.
19. Köhrle J, Gärtner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab 2009; 23:815-827.
20. Schweizer U, Weitzel JM, Schomburg L. Think globally: act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas. Mol Cell Endocrinol 2008; 289:1-9.
21. Gereben B, Zavacki AM, Ribich S, et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 2008; 29:898-938.
22. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 2007; 9:775-806. (Pubitemid 46919583)
23. Seeher S, Mahdi Y, Schweizer U. Posttranscriptional control of selenoprotein biosynthesis. Curr Protein Pept Sci 2012; 13:337-346.
24. Schomburg L. Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nat Rev Endocrinol 2011; 8:160-171.
25. Dumitrescu AM, Di Cosmo C, Liao XH, et al. The syndrome of inherited partial SBP2 deficiency in humans. Antioxid Redox Signal 2010; 12:905-920.
26. Schomburg L, Dumitrescu AM, Liao XH, et al. Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 2009; 19:277-281.
27. Schomburg L, Riese C, Michaelis M, et al. Synthesis and metabolism of thyroid hormones is preferentially maintained in selenium-deficient transgenic mice. Endocrinology 2006; 147:1306-1313. (Pubitemid 43244364)
28. Gross M, Oertel M, Köhrle J. Differential selenium-dependent expression of type I 5'-deiodinase and glutathione peroxidase in the porcine epithelial kidney cell line LLC-PK1. Biochem J 1995; 306 (Pt 3):851-856.
29. Chiu-Ugalde J, Wirth EK, Klein MO, et al. Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxid Redox Signal 2012; 17:902-913.
30. Behne D, Hilmert H, Scheid S, et al. Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim Biophys Acta 1988; 966:12-21.
31. Fairweather-Tait SJ, Bao Y, Broadley MR, et al. Selenium in human health and disease. Antioxid Redox Signal 2011; 14:1337-1383.
32. Renko K, Hofmann PJ, Stoedter M, et al. Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice. FASEB J 2009; 23:1758-1765.
33. Schomburg L, Schweizer U, Holtmann B, et al. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 2003; 370 (Pt 2):397-402. (Pubitemid 36315127)
34. Burk RF, Hill KE, Motley AK, et al. Deletion of selenoprotein P upregulates urinary selenium excretion and depresses whole-body selenium content. Biochim Biophys Acta 2006; 1760:1789-1793. (Pubitemid 44692379)
35. Olson GE, Winfrey VP, Nagdas SK, et al. Apolipoprotein E receptor-2 (ApoER2) mediates selenium uptake from selenoprotein P by the mouse testis. J Biol Chem 2007; 282:12290-12297. (Pubitemid 47100729)
36. Schweizer U, Dehina N, Schomburg L. Disorders of selenium metabolism and selenoprotein function. Curr Opin Pediatr 2011; 23:429-435.
37. Schmutzler C, Mentrup B, Schomburg L, et al. Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol Chem 2007; 388:1053-1059. (Pubitemid 47584302)
38. Schweizer U, Chiu J, Köhrle J. Peroxides and peroxide-degrading enzymes in the thyroid. Antioxid Redox Signal 2008; 10:1577-1592. (Pubitemid 351931931)
39. Golstein J, Corvilain B, Lamy F, et al. Effects of a selenium deficient diet on thyroid function of normal and perchlorate treated rats. Acta Endocrinol (Copenh) 1988; 118:495-502.
40. Shchedrina VA, Zhang Y, Labunskyy VM, et al. Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Antioxid Redox Signal 2010; 12:839-849.
41. Roy G, Mugesh G. Selenium analogues of antithyroid drugs-recent developments. Chem Biodivers 2008; 5:414-439.
42. Weissel M. Propylthiouracil: clinical overview of its efficacy and its side effects more than 50 years after the introduction of its use in thyrostatic treatment. Exp Clin Endocrinol Diabetes 2010; 118:101-104.
43. Gershengorn MC, Neumann S. Update in TSH receptor agonists and antagonists. J Clin Endocrinol Metab 2012; 97:4287-4292.
44. Xu XM, Carlson BA, Irons R, et al. Selenophosphate synthetase 2 is essential for selenoprotein biosynthesis. Biochem J 2007; 404:115-120. (Pubitemid 46788091)
45. Turanov AA, Xu XM, Carlson BA, et al. Biosynthesis of selenocysteine, the 21st amino acid in the genetic code, and a novel pathway for cysteine biosynthesis. Adv Nutr 2011; 2:122-128.
46. Burk RF, Hill KE. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 2005; 25:215-235. (Pubitemid 41209001)
47. Burk RF, Norsworthy BK, Hill KE, et al. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev 2006; 15:804-810.
48. Hollenbach B, Morgenthaler NG, Struck J, et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 2008; 22:24-32.
49. Hoeflich J, Hollenbach B, Behrends T, et al. The choice of biomarkers determines the selenium status in young German vegans and vegetarians. Br J Nutr 2010; 104:1601-1604.
50. Combs GF Jr, Watts JC, Jackson MI, et al. Determinants of selenium status in healthy adults. Nutr J 2011; 10:75.
51. Xia Y, Hill KE, Li P, et al. Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects. Am J Clin Nutr 2010; 92:525-531.
52. Hurst R, Armah CN, Dainty JR, et al. Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2010; 91:923-931.
53. Ashton K, Hooper L, Harvey LJ, et al. Methods of assessment of selenium status in humans: a systematic review. Am J Clin Nutr 2009; 89:2025S-2039S.
54. Derumeaux H, Valeix P, Castetbon K, et al. Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur J Endocrinol 2003; 148:309-315. (Pubitemid 36410716)
55. Rasmussen LB, Schomburg L, Köhrle J, et al. Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. Eur J Endocrinol 2011; 164:585-590.
56. Pedersen IB, Knudsen N, Carlé A, et al. Serum selenium is low in newly diagnosed Graves' disease: a population-based study. Clin Endocrinol (Oxf) 2013; doi: 10.1111/cen.12185. [Epub ahead of print].
57. van Zuuren EJ, Albusta AY, Fedorowicz Z, et al. Selenium supplementation for Hashimoto's thyroiditis. Cochrane Database Syst Rev 2013; 6: CD010223.
58. Glattre E, Nygård JF, Aaseth J. Selenium and cancer prevention: observations and complexity. J Trace Elem Med Biol 2012; 26:168-169.
59. Pellegriti G, Frasca F, Regalbuto C, et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013; 965212.
60. Davis CD, Tsuji PA, Milner JA. Selenoproteins and cancer prevention. Annu Rev Nutr 2012; 32:73-95.
61. Rayman MP. Selenium and human health. Lancet 2012; 379:1256-1268.
62. Hotz CS, Fitzpatrick DW, Trick KD, L'Abbé MR. Dietary Iodine and selenium interact to affect thyroid hormone metabolism of rats. J Nutr 1997; 127:1214-1218. (Pubitemid 27242122)
63. Rasmussen LB, Hollenbach B, Laurberg P, et al. Serum selenium and selenoprotein P status in adult Danes - 8-year followup. J Trace Elem Med Biol 2009; 23:265-271.
64. Brauer VF, Schweizer U, Köhrle J, Paschke R. Selenium and goiter prevalence in borderline iodine sufficiency. Eur J Endocrinol 2006; 155:807-812. (Pubitemid 46040618)
65. Huang Z, Rose AH, Hoffmann PR. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2012; 16:705-743.
66. Toulis KA, Anastasilakis AD, Tzellos TG, et al. Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a metaanalysis. Thyroid 2010; 20:1163-1173.
67. Drutel A, Archambeaud F, Caron P. Selenium and the thyroid gland. More Good News for Clinicians. Clin Endocrinol 2013; 78:155-164.
68. Negro R, Greco G, Mangieri T, et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007; 92:1263-1268. (Pubitemid 46556396)
69. Rayman MP, Thompson AJ, Bekaert B, et al. Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. Am J Clin Nutr 2008; 87:370-378. (Pubitemid 351226073)
70. Combs GF Jr, Midthune DN, Patterson KY, et al. Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults. Am J Clin Nutr 2009; 89:1808-1814.
71. Thomson CD, Campbell JM, Miller J, et al. Selenium and iodine supplementation: effect on thyroid function of older New Zealanders. Am J Clin Nutr 2009; 90:1038-1046.
72. Marcocci C, Kahaly GJ, Krassas GE, et al., European Group on Graves' Orbitopathy. Selenium and the course of mild Graves' orbitopathy. N Engl J Med 2011; 364:1920-1931.
73. Watt T, Cramon P, Bjorner JB, et al. Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial. Trials 2013; 14:119.